Launch of the IRAZU Project (PHRC-K 2018)


The IRAZU project focuses on the impact of cardiovascular co-morbidities on the efficacy of bevacizumab, in real care setting, in elderly subjects with metastatic colorectal cancer. Information concerning the evaluation of the effect of treatments in the elderly is often missing in clinical trials, especially when the interest resides on the effect of another disease on the treatment results. This evaluation will be conducted analyzing the data from the Nationwide Health Insurance System databases SNDS.